Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Interferon response factor 3 is crucial to poly-I:C induced NK cell activity and control of B16 melanoma growth.

Moore TC, Kumm PM, Brown DM, Petro TM.

Cancer Lett. 2014 Apr 28;346(1):122-8. doi: 10.1016/j.canlet.2013.12.022. Epub 2013 Dec 22.

2.

INAM plays a critical role in IFN-γ production by NK cells interacting with polyinosinic-polycytidylic acid-stimulated accessory cells.

Kasamatsu J, Azuma M, Oshiumi H, Morioka Y, Okabe M, Ebihara T, Matsumoto M, Seya T.

J Immunol. 2014 Nov 15;193(10):5199-207. doi: 10.4049/jimmunol.1400924. Epub 2014 Oct 15.

3.

Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways.

Miyake T, Kumagai Y, Kato H, Guo Z, Matsushita K, Satoh T, Kawagoe T, Kumar H, Jang MH, Kawai T, Tani T, Takeuchi O, Akira S.

J Immunol. 2009 Aug 15;183(4):2522-8. doi: 10.4049/jimmunol.0901500. Epub 2009 Jul 27.

4.

Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models.

Shime H, Kojima A, Maruyama A, Saito Y, Oshiumi H, Matsumoto M, Seya T.

J Innate Immun. 2014;6(3):293-305. doi: 10.1159/000355126. Epub 2013 Oct 29.

PMID:
24192491
5.

Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation.

Ebihara T, Azuma M, Oshiumi H, Kasamatsu J, Iwabuchi K, Matsumoto K, Saito H, Taniguchi T, Matsumoto M, Seya T.

J Exp Med. 2010 Nov 22;207(12):2675-87. doi: 10.1084/jem.20091573. Epub 2010 Nov 8. Erratum in: J Exp Med. 2015 Jul 27;212(8):1337.

8.

The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.

Steinberg C, Eisenächer K, Gross O, Reindl W, Schmitz F, Ruland J, Krug A.

Eur J Immunol. 2009 Apr;39(4):1007-18. doi: 10.1002/eji.200838814.

9.

Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.

Kuhn S, Hyde EJ, Yang J, Rich FJ, Harper JL, Kirman JR, Ronchese F.

J Immunol. 2013 Aug 15;191(4):1984-92. doi: 10.4049/jimmunol.1301135. Epub 2013 Jul 15.

10.

IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma.

Jiang Q, Wei H, Tian Z.

J Immunother. 2008 Jul-Aug;31(6):555-62. doi: 10.1097/CJI.0b013e31817d8e75.

PMID:
18528299
11.

Defective antitumor responses in CX3CR1-deficient mice.

Yu YR, Fong AM, Combadiere C, Gao JL, Murphy PM, Patel DD.

Int J Cancer. 2007 Jul 15;121(2):316-22.

12.

Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells.

Akazawa T, Ebihara T, Okuno M, Okuda Y, Shingai M, Tsujimura K, Takahashi T, Ikawa M, Okabe M, Inoue N, Okamoto-Tanaka M, Ishizaki H, Miyoshi J, Matsumoto M, Seya T.

Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):252-7. Epub 2006 Dec 26.

13.

Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.

Wei H, Zheng X, Lou D, Zhang L, Zhang R, Sun R, Tian Z.

Mol Immunol. 2005 May;42(9):1023-31. Epub 2004 Nov 23.

PMID:
15829292
14.
15.

Correlation of immunomodulatory and therapeutic activities of interferon and interferon inducers in metastatic disease.

Black PL, Phillips H, Tribble HR, Pennington R, Schneider M, Talmadge JE.

J Cell Biochem. 1988 Apr;36(4):377-92.

PMID:
3132467
16.

Wiskott-Aldrich syndrome protein deficiency in natural killer and dendritic cells affects antitumor immunity.

Catucci M, Zanoni I, Draghici E, Bosticardo M, Castiello MC, Venturini M, Cesana D, Montini E, Ponzoni M, Granucci F, Villa A.

Eur J Immunol. 2014 Apr;44(4):1039-45. doi: 10.1002/eji.201343935. Epub 2014 Jan 13.

17.

NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection.

Salazar-Mather TP, Ishikawa R, Biron CA.

J Immunol. 1996 Oct 1;157(7):3054-64.

PMID:
8816415
18.

Enhanced suppression of pulmonary metastasis of malignant melanoma cells by combined administration of alpha-galactosylceramide and interleukin-18.

Nishio S, Yamada N, Ohyama H, Yamanegi K, Nakasho K, Hata M, Nakamura Y, Fukunaga S, Futani H, Yoshiya S, Ueda H, Taniguchi M, Okamura H, Terada N.

Cancer Sci. 2008 Jan;99(1):113-20. Epub 2007 Oct 18.

19.

Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.

Wang J, Sun R, Wei H, Dong Z, Gao B, Tian Z.

J Hepatol. 2006 Mar;44(3):446-54. Epub 2005 Sep 21.

PMID:
16310275
20.

Early activation and interferon-γ production of tumor-infiltrating mature CD27 high natural killer cells.

Hayakawa Y, Sato-Matsushita M, Takeda K, Iwakura Y, Tahara H, Irimura T.

Cancer Sci. 2011 Nov;102(11):1967-71. doi: 10.1111/j.1349-7006.2011.02042.x. Epub 2011 Aug 21.

Supplemental Content

Support Center